Results
16
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
16 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
HO | €137.45 | -0.4% | 2.3% | €28.2b | €175.56 | PE29.6x | E20.1% | 2.5% | Capital Goods | ||
AIR | €154.78 | -3.4% | 11.0% | €122.4b | €167.00 | PE37.5x | E23.1% | 1.2% | Capital Goods | ||
BOL | €5.76 | -3.4% | 3.0% | €16.3b | €6.43 | PE105.9x | E32.7% | 1.2% | Media | ||
DIM | €185.20 | -4.6% | -23.6% | €18.0b | €222.53 | PE112.2x | E32.0% | 0.4% | Pharmaceuticals & Biotech | ||
SAF | €210.00 | 0.4% | 31.4% | €88.3b | €236.21 | PE53.9x | E19.3% | 1.0% | Capital Goods | ||
URW | €71.66 | -3.1% | 6.7% | €10.0b | €85.73 | PB0.6x | E65.9% | 3.5% | Real Estate | ||
ALO | €21.92 | -1.0% | 82.6% | €10.1b | €23.52 | PS0.6x | E58.2% | 0% | Capital Goods | ||
BIM | €102.20 | 0.1% | 1.2% | €12.1b | €118.70 | PE29.3x | E13.7% | 0.8% | Healthcare | ||
SU | €239.75 | -2.0% | 32.5% | €134.5b | €250.53 | PE34.8x | E14.0% | 1.5% | Capital Goods | ||
DSY | €33.15 | -5.2% | -25.7% | €43.6b | €37.65 | PE39x | E13.5% | 0.7% | Software | ||
AM | €191.30 | 0.6% | 6.2% | €14.9b | €223.69 | PE18.5x | E15.2% | 1.8% | Capital Goods | ||
EL | €231.20 | 0% | 27.2% | €105.6b | €222.60 | PE46.1x | E15.2% | 1.7% | Healthcare | ||
OR New | €336.95 | -1.9% | -24.7% | €180.3b | €398.60 | PE27.8x | E7.5% | 2.0% | Household | ||
RMS | €2,304.00 | 1.3% | 18.7% | €241.3b | €2,271.36 | PE54.2x | E9.2% | 0.7% | Consumer Durables | ||
BVI | €28.78 | -4.4% | 27.3% | €12.9b | €33.29 | PE25.5x | E9.9% | 2.9% | Commercial Services | ||
RNO | €46.82 | 4.6% | 24.2% | €12.6b | €56.84 | PE9x | E26.8% | 4.0% | Automobiles |